1. Home
  2. TSLX vs FTRE Comparison

TSLX vs FTRE Comparison

Compare TSLX & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$17.53

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.09

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
FTRE
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2011
2023

Fundamental Metrics

Financial Performance
Metric
TSLX
FTRE
Price
$17.53
$9.09
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$21.72
$15.39
AVG Volume (30 Days)
1.3M
1.4M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
11.59%
N/A
EPS Growth
N/A
N/A
EPS
1.81
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.92
$3.01
P/E Ratio
$9.77
N/A
Revenue Growth
N/A
1.00
52 Week Low
$16.99
$3.97
52 Week High
$25.17
$18.67

Technical Indicators

Market Signals
Indicator
TSLX
FTRE
Relative Strength Index (RSI) 37.01 35.46
Support Level $17.15 $8.85
Resistance Level $18.57 $11.22
Average True Range (ATR) 0.46 0.57
MACD 0.04 0.16
Stochastic Oscillator 15.12 26.11

Price Performance

Historical Comparison
TSLX
FTRE

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: